» Articles » PMID: 38668065

Prehabilitation in Adults Undergoing Cancer Surgery: A Comprehensive Review on Rationale, Methodology, and Measures of Effectiveness

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2024 Apr 26
PMID 38668065
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer surgery places a significant burden on a patients' functional status and quality of life. In addition, cancer surgery is fraught with postoperative complications, themselves influenced by a patient's functional status. Prehabilitation is a unimodal or multimodal strategy that aims to increase a patient's functional capacity to reduce postoperative complications and improve postoperative recovery and quality of life. In most cases, it involves exercise, nutrition, and anxiety-reducing interventions. The impact of prehabilitation has been explored in several types of cancer surgery, most commonly colorectal and thoracic. Overall, the existing evidence suggests prehabilitation improves physiological outcomes (e.g., lean body mass, maximal oxygen consumption) as well as clinical outcomes (e.g., postoperative complications, quality of life). Notably, the benefit of prehabilitation is additional to that of enhanced recovery after surgery (ERAS) programs. While safe, prehabilitation programs require multidisciplinary coordination preoperatively. Despite the existence of numerous systematic reviews and meta-analyses, the certainty of evidence demonstrating the efficacy and safety of prehabilitation is low to moderate, principally due to significant methodological heterogeneity and small sample sizes. There is a need for more large-scale multicenter randomized controlled trials to draw strong clinical recommendations.

Citing Articles

Patient Education on Exercise Prehabilitation Among Patients Receiving Neoadjuvant Therapy for Cancer Surgery in China: A Mixed-Methods Study.

Xu X, Zhang J, Zhang Y, Yang T, Yu X Healthcare (Basel). 2025; 13(5).

PMID: 40077038 PMC: 11899062. DOI: 10.3390/healthcare13050477.


Preoperative determinants of normative postoperative recovery rate following minimally invasive repair of pectus excavatum.

Carter M, Chen A, Pitt J, Hua R, Edobor A, Kwon S Pediatr Surg Int. 2024; 40(1):309.

PMID: 39546039 DOI: 10.1007/s00383-024-05889-5.


Prognostic value of serum 25-hydroxyvitamin D levels and malnutrition status on postoperative complications in patients following laryngectomy with neck dissection.

Radivojevic N, Sipetic Grujicic S, Suljagic V, Stojkovic S, Arsovic K, Jakovljevic S Eur Arch Otorhinolaryngol. 2024; 282(1):341-349.

PMID: 39438295 DOI: 10.1007/s00405-024-09046-5.


A cross-sectional survey of prehabilitation among surgeons and anesthesiologists.

Sato M, Ida M, Nakatani S, Kawaguchi M JA Clin Rep. 2024; 10(1):66.

PMID: 39404964 PMC: 11480281. DOI: 10.1186/s40981-024-00749-6.


Development of Machine Learning Models for Predicting the 1-Year Risk of Reoperation After Lower Limb Oncological Resection and Endoprosthetic Reconstruction Based on Data From the PARITY Trial.

Deng J, Moskalyk M, Shammas-Toma M, Aoude A, Ghert M, Bhatnagar S J Surg Oncol. 2024; 130(8):1706-1716.

PMID: 39257289 PMC: 11849712. DOI: 10.1002/jso.27854.

References
1.
Krampe H, Goerling U, Spies C, Gerhards S, Enge S, Salz A . Sense of coherence, mental well-being and perceived preoperative hospital and surgery related stress in surgical patients with malignant, benign, and no neoplasms. BMC Psychiatry. 2020; 20(1):567. PMC: 7693497. DOI: 10.1186/s12888-020-02953-x. View

2.
Bhat I, Okiror L, Nair A, Bille A . Impact of waiting times on tumour growth and pathologic upstaging in patients with non-small cell lung cancer having lung resection. Tumori. 2020; 107(4):329-334. DOI: 10.1177/0300891620960217. View

3.
Bojesen R, Dalton S, Skou S, Jorgensen L, Walker L, Eriksen J . Preoperative multimodal prehabilitation before elective colorectal cancer surgery in patients with WHO performance status I or II: randomized clinical trial. BJS Open. 2023; 7(6). PMC: 10702628. DOI: 10.1093/bjsopen/zrad134. View

4.
Fang P, Zhou J, Xiao X, Yang Y, Luan S, Liang Z . The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022; 14(1):3-16. PMC: 9891912. DOI: 10.1002/jcsm.13126. View

5.
Yen C, Yang Y, Ku H, Hu H, Lo S, Chang H . The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study. Cancer Med. 2023; 12(16):16906-16917. PMC: 10501262. DOI: 10.1002/cam4.6320. View